Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Machine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway Modeling.

Cuperlovic-Culf M.

Metabolites. 2018 Jan 11;8(1). pii: E4. doi: 10.3390/metabo8010004. Review.

2.

Database of resistance related metabolites in Wheat Fusarium head blight Disease (MWFD).

Surendra A, Cuperlovic-Culf M.

Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax076.

3.

Metabolomics and Cheminformatics Analysis of Antifungal Function of Plant Metabolites.

Cuperlovic-Culf M, Rajagopalan N, Tulpan D, Loewen MC.

Metabolites. 2016 Sep 30;6(4). pii: E31.

4.

Metabolic Effect of Estrogen Receptor Agonists on Breast Cancer Cells in the Presence or Absence of Carbonic Anhydrase Inhibitors.

Belkaid A, Čuperlović-Culf M, Touaibia M, Ouellette RJ, Surette ME.

Metabolites. 2016 May 26;6(2). pii: E16. doi: 10.3390/metabo6020016.

5.

New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.

Roy PP, D'Souza K, Cuperlovic-Culf M, Kienesberger PC, Touaibia M.

Eur J Med Chem. 2016 Aug 8;118:290-8. doi: 10.1016/j.ejmech.2016.04.021. Epub 2016 Apr 10.

PMID:
27155760
6.

Metabolic Biomarker Panels of Response to Fusarium Head Blight Infection in Different Wheat Varieties.

Cuperlovic-Culf M, Wang L, Forseille L, Boyle K, Merkley N, Burton I, Fobert PR.

PLoS One. 2016 Apr 21;11(4):e0153642. doi: 10.1371/journal.pone.0153642. eCollection 2016.

7.

A spectroscopic study of substituted anthranilic acids as sensitive environmental probes for detecting cancer cells.

Culf AS, Yin H, Monro S, Ghosh A, Barnett DA, Ouellette RJ, Čuperlović-Culf M, McFarland SA.

Bioorg Med Chem. 2016 Mar 1;24(5):929-37. doi: 10.1016/j.bmc.2015.12.044. Epub 2015 Dec 29.

PMID:
26810709
8.

(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.

Cuperlovic-Culf M, Cormier K, Touaibia M, Reyjal J, Robichaud S, Belbraouet M, Turcotte S.

Int J Cancer. 2016 May 15;138(10):2439-49. doi: 10.1002/ijc.29947. Epub 2016 Jan 29.

9.

Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.

St-Coeur PD, Poitras JJ, Cuperlovic-Culf M, Touaibia M, Morin P Jr.

J Neurooncol. 2015 Oct;125(1):91-102. doi: 10.1007/s11060-015-1899-6. Epub 2015 Aug 28.

PMID:
26311249
10.

Influence of HEK293 metabolism on the production of viral vectors and vaccine.

Petiot E, Cuperlovic-Culf M, Shen CF, Kamen A.

Vaccine. 2015 Nov 4;33(44):5974-81. doi: 10.1016/j.vaccine.2015.05.097. Epub 2015 Jun 11. Review.

PMID:
26073013
11.

Metal-Free, Acid-Catalyzed ortho-Directed Synthesis of Anthranilic Acid Derivatives Using Carbodiimides.

Culf AS, Čuperlović-Culf M, Ouellette RJ, Decken A.

Org Lett. 2015 Jun 5;17(11):2744-7. doi: 10.1021/acs.orglett.5b01160. Epub 2015 May 20.

PMID:
25990766
12.

Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide.

Cuperlovic-Culf M, Touaibia M, St-Coeur PD, Poitras J, Morin P, Culf AS.

Metabolites. 2014 Sep 12;4(3):807-30. doi: 10.3390/metabo4030807.

13.

Small head-to-tail macrocyclic α-peptoids.

Culf AS, Čuperlović-Culf M, Léger DA, Decken A.

Org Lett. 2014 May 16;16(10):2780-3. doi: 10.1021/ol501102b. Epub 2014 May 5. Erratum in: Org Lett. 2014 Sep 19;16(18):4967.

PMID:
24797336
14.

¹H NMR metabolomics analysis of the effect of dichloroacetate and allopurinol on breast cancers.

Lefort N, Brown A, Lloyd V, Ouellette R, Touaibia M, Culf AS, Cuperlovic-Culf M.

J Pharm Biomed Anal. 2014 May;93:77-85. doi: 10.1016/j.jpba.2013.08.017. Epub 2013 Sep 8.

PMID:
24074721
15.

Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.

St-Coeur PD, Touaibia M, Cuperlovic-Culf M, Morin P Jr.

Genomics Proteomics Bioinformatics. 2013 Aug;11(4):199-206. doi: 10.1016/j.gpb.2013.04.003. Epub 2013 Jun 1. Review.

16.

NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.

Morin P Jr, Ferguson D, LeBlanc LM, Hébert MJ, Paré AF, Jean-François J, Surette ME, Touaibia M, Cuperlovic-Culf M.

J Proteome Res. 2013 May 3;12(5):2165-76. doi: 10.1021/pr400026q. Epub 2013 Apr 22.

PMID:
23557402
17.

1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics.

Cuperlovic-Culf M, Ferguson D, Culf A, Morin P Jr, Touaibia M.

J Biol Chem. 2012 Jun 8;287(24):20164-75. doi: 10.1074/jbc.M111.337196. Epub 2012 Apr 23.

18.

MetaboHunter: an automatic approach for identification of metabolites from 1H-NMR spectra of complex mixtures.

Tulpan D, Léger S, Belliveau L, Culf A, Cuperlović-Culf M.

BMC Bioinformatics. 2011 Oct 14;12:400. doi: 10.1186/1471-2105-12-400.

19.

Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.

Doiron J, Soultan AH, Richard R, Touré MM, Picot N, Richard R, Cuperlović-Culf M, Robichaud GA, Touaibia M.

Eur J Med Chem. 2011 Sep;46(9):4010-24. doi: 10.1016/j.ejmech.2011.05.074. Epub 2011 Jun 12.

PMID:
21703734
20.

Multi-gene biomarker panel for reference free prostate cancer diagnosis: determination and independent validation.

Cuperlovic-Culf M, Belacel N, Davey M, Ouellette RJ.

Biomarkers. 2010 Dec;15(8):693-706. doi: 10.3109/1354750X.2010.511268. Epub 2010 Oct 1.

PMID:
20883156

Supplemental Content

Loading ...
Support Center